Hiv Splicing

HIV splicing is the regulated processing of viral RNA that enables one compact genome to produce diverse viral proteins, making it central to HIV replication and immune evasion. After host RNA polymerase II transcribes the integrated provirus, the cellular spliceosome recognizes viral splice donor and acceptor sites to generate unspliced, singly spliced, and multiply spliced messenger RNAs. These RNA classes encode structural proteins and regulatory factors, while the viral Rev protein promotes nuclear export of incompletely spliced transcripts through the Rev response element. Studying HIV splicing clarifies host-virus interactions and supports antiviral strategies that disrupt RNA processing, export, or protein production.

Hiv Splicing - Related Videos

Education

JoVE Core - Biology

RNA Splicing

0 Views •

2019

Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...

Alternative RNA Splicing

0 Views •

2020

Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity. There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...

Research

JoVE Journal - Immunology and Infection
Free Sample

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

0 Views •

Cited by 15 •

2014

Here we describe cellular cytotoxicity and single round infectivity assays that allow for the rapid and accurate screening of compounds to determine their cellular cytotoxicity (CC50) and IC50 values against WT and drug resistant HIV-1.

High Throughput In Vitro Assessment of Latency Reversing Agents on HIV Transcription and Splicing

0 Views •

2019

A high throughput protocol for functional assessment of HIV efficient reactivation and clearance of latent proviruses is described and applied by testing the impact of interventions on HIV transcription and splicing. Representative results of the effect of latency reversing agents on LTR-driven transcription and splicing are provided.

Amplifying and Quantifying HIV-1 RNA in HIV Infected Individuals with Viral Loads Below the Limit of Detection by Standard Clinical Assays

0 Views •

Cited by 10 •

2011

Quantifying levels of HIV-1 RNA in plasma and sequencing single HIV-1 genomes from individuals with viral loads below the limit of detection (50-75 copies/ml) is difficult. Here we describe how to extract and quantify plasma viral RNA using a real time PCR assay that reliably measures HIV-1 RNA down to 0.3 copies/ml and how to amplify viral genomes by single genome sequencing, from samples with very low viral loads.

View All Results

FAQs

Related Topics